Literature DB >> 6954529

Leukemogenesis by Gross passage A murine leukemia virus: expression of viruses with recombinant env genes in transformed cells.

N G Famulari, C F Koehne, P V O'Donnell.   

Abstract

Gross passage A murine leukemia virus (MuLV) derived from extracts of C3Hf/Bi mouse leukemias has been shown to be a virus complex consisting of ecotropic, xenotropic, and recombinant, dualtropic MuLV components. The three virus components were distinguished biochemically by differences in the molecular weights and peptide maps of their primary env gene products synthesized in infected cells in vivo and in vitro. Virus expression was studied in primary leukemias induced in C3Hf/Bi mice by Gross passage A virus extracts and by the individual ecotropic and recombinant MuLV components that were isolated in vitro. Our findings suggest that expression of the recombinant MuLV component of the Gross passage A virus complex is necessary and sufficient for the induction of leukemias in C3Hf/Bi mice. In contrast, induction of leukemias by the ecotropic virus component appears to involve generation of a second virus with characteristics of recombinant, dualtropic MuLV.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6954529      PMCID: PMC346530          DOI: 10.1073/pnas.79.12.3872

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Biological, immunological, and biochemical evidence that HIX virus is a recombinant between Moloney leukemia virus and a murine xenotropic C type virus.

Authors:  P J Fischinger; A E Frankel; J H Elder; R A Lerner; J N Ihle; D P Bolognesi
Journal:  Virology       Date:  1978-10-15       Impact factor: 3.616

2.  Biochemical evidence that MCF murine leukemia viruses are envelope (env) gene recombinants.

Authors:  J H Elder; J W Gautsch; F C Jensen; R A Lerner; J W Hartley; W P Rowe
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

3.  Characterization and mapping of RNase T1-resistant oligonucleotides derived from the genomes of Akv and MCF murine leukemia viruses.

Authors:  J Rommelaere; D V Faller; N Hopkins
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

4.  Heteroduplex analysis of the sequence relations between the RNAs of mink cell focus-inducing and murine leukemia viruses.

Authors:  Y H Chien; I M Verma; T Y Shih; E M Scolnick; N Davidson
Journal:  J Virol       Date:  1978-10       Impact factor: 5.103

5.  Oncogenicity of AKR endogenous leukemia viruses.

Authors:  R C Nowinski; E F Hays
Journal:  J Virol       Date:  1978-07       Impact factor: 5.103

6.  Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis.

Authors:  D W Cleveland; S G Fischer; M W Kirschner; U K Laemmli
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

7.  A new class of murine leukemia virus associated with development of spontaneous lymphomas.

Authors:  J W Hartley; N K Wolford; L J Old; W P Rowe
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

8.  Genomic masking of nondefective recombinant murine leukemia virus in Moloney virus stocks.

Authors:  P J Fischinger; C S Blevins; N M Dunlop
Journal:  Science       Date:  1978-08-04       Impact factor: 47.728

9.  Acquisition of oncogenicity by endogenous mouse type C viruses: effects of variations in env and gag genes.

Authors:  S G Devare; U R Rapp; G J Todaro; J R Stephenson
Journal:  J Virol       Date:  1978-11       Impact factor: 5.103

10.  Relative loss of oncogenic potency of mouse leukemia virus (Gross) after prolonged propagation in tissue culture.

Authors:  L Gross; Y Dreyfuss
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

View more
  11 in total

1.  Genetic determinants of neoplastic diseases induced by a subgroup F avian leukosis virus.

Authors:  M C Simon; W S Neckameyer; W S Hayward; R E Smith
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

2.  Cytolytic T lymphocyte-defined retroviral antigens on normal cells: encoding by the Akv-1 proviral locus.

Authors:  W R Green; R F Graziano
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

3.  Association of recombinant murine leukemia viruses of the class II genotype with spontaneous lymphomas in CWD mice.

Authors:  C Y Thomas; B J Boykin; N G Famulari; M A Coppola
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

4.  AKR ecotropic murine leukemia virus SL3-3 forms envelope gene recombinants in vivo.

Authors:  C Y Thomas
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

5.  Role of recombinant ecotropic and polytropic viruses in the development of spontaneous thymic lymphomas in HRS/J mice.

Authors:  C Y Thomas; R Khiroya; R S Schwartz; J M Coffin
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

6.  Somatically acquired recombinant murine leukemia proviruses in thymic leukemias of AKR/J mice.

Authors:  W Herr; W Gilbert
Journal:  J Virol       Date:  1983-04       Impact factor: 5.103

7.  The tandem direct repeats within the long terminal repeat of murine leukemia viruses are the primary determinant of their leukemogenic potential.

Authors:  L DesGroseillers; P Jolicoeur
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

8.  Thymic epithelial genotype influences the production of recombinant leukemogenic retroviruses in mice.

Authors:  S K Datta; C Y Thomas; J A Nicklas; J M Coffin
Journal:  J Virol       Date:  1983-07       Impact factor: 5.103

9.  The high leukemogenic potential of Gross passage A murine leukemia virus maps in the region of the genome corresponding to the long terminal repeat and to the 3' end of env.

Authors:  L DesGroseillers; R Villemur; P Jolicoeur
Journal:  J Virol       Date:  1983-07       Impact factor: 5.103

10.  Molecular cloning of viral DNA from leukemogenic Gross passage A murine leukemia virus and nucleotide sequence of its long terminal repeat.

Authors:  R Villemur; E Rassart; L DesGroseillers; P Jolicoeur
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.